Aldeyra Therapeutics Inc (NASDAQ:ALDX)
| 8.51 Delayed Data As of Sep 24 |  +0.11 / +1.31%Today’s Change | 6.21 Today|||52-Week Range 15.95 | +24.05% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 14.6M | 12.0M | 20.0M | 47.4M | |
| Short Term Investment Cash | 6.1M | -2.6M | 8.0M | 27.3M | ||
| Cash & Short Term Investments | 27.6M | 24.9M | 42.9M | 93.6M | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 497.6K | 218.7K | 1.0M | 1.2M | |
| Current Assets | 28.1M | 25.1M | 44.0M | 94.8M | ||
| Total Assets | Other Assets | 36.2K | 0.00 | 165.9K | 86.6K | |
| Total Assets | 28.2M | 25.2M | 44.2M | 95.1M | ||
| Liabilities | Accounts Payable | 0.00 | 0.00 | 1.0M | 3.1M | |
| Short Term Debt | 77.5K | 77.5K | 116.3K | 0.00 | ||
| Accrued Expenses | 791.7K | 962.8K | 1.4M | 4.2M | ||
| Other Current Liabilities | 1.6M | 1.2M | 1.4M | 4.2M | ||
| Other Liabilities | 2.1M | 2.3M | 3.4M | 8.5M | ||
| Total Liabilities | Long Term Debt | 1.2M | 1.2M | 1.2M | 0.00 | |
| Total Liabilities | 3.3M | 3.5M | 4.6M | 8.5M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 24.9M | 21.6M | 39.6M | 86.6M | ||
| Total Shareholder Equity | 24.9M | 21.6M | 39.6M | 86.6M | ||
| Share Information | Common Shares Outstanding | 9.7M | 12.6M | 19.1M | 26.2M | |
| Addtl. Info. | No data currently available for this section. | |||||
